Publicação
Comorbidities and medication intake among people with dementia living in long-term care facilities
| Resumo: | ABSTRACT - Information on comorbidities and medication of people with dementia (PWD) in long- term-facilities (LTF) is scarce. This study analysed type and number of comorbidities and medication of PWD in LTF. A descriptive-study was conducted in 40 LTF, characterising 329 PWD. Socio-demographics, dementia type, comorbidities and medication were collected with International-Classification-of-Functionality-checklist. Cognitive impairment was assessed with Mini-Mental-State-Examination. One or more comorbidities (2.1 ± 1.6) were found in 271 participants. Hypertension, osteoarticular-problems, heart-disease and type-II-diabetes were the frequently comorbidities. 327 participants consumed one or more medicines (7.3 ± 3.2), mainly for cardiovascular system, anxiolytics and antipsychotics. Comorbidities and medication amount was significantly different among cognitive impairment levels. Vascular comorbidities were present in all dementia types. |
|---|---|
| Autores principais: | Marques, Alda |
| Outros Autores: | Rocha, Vânia; Pinto, Margarida; Sousa, Liliana; Figueiredo, Daniela |
| Assunto: | People with dementia Comorbidities Medication Long-term care facilities Pessoas com demência Comorbilidades Medicação Lares de idosos |
| Ano: | 2015 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | ABSTRACT - Information on comorbidities and medication of people with dementia (PWD) in long- term-facilities (LTF) is scarce. This study analysed type and number of comorbidities and medication of PWD in LTF. A descriptive-study was conducted in 40 LTF, characterising 329 PWD. Socio-demographics, dementia type, comorbidities and medication were collected with International-Classification-of-Functionality-checklist. Cognitive impairment was assessed with Mini-Mental-State-Examination. One or more comorbidities (2.1 ± 1.6) were found in 271 participants. Hypertension, osteoarticular-problems, heart-disease and type-II-diabetes were the frequently comorbidities. 327 participants consumed one or more medicines (7.3 ± 3.2), mainly for cardiovascular system, anxiolytics and antipsychotics. Comorbidities and medication amount was significantly different among cognitive impairment levels. Vascular comorbidities were present in all dementia types. |
|---|